Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1960 Feb;32(4):241–249.

The Case for Live Poliovirus Vaccination **

John R Paul
PMCID: PMC2604088  PMID: 14430990

Full text

PDF
241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COURTOIS G., FLACK A., JERVIS G. A., KOPROWSKI H., NINANE G. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi. Br Med J. 1958 Jul 26;2(5090):187–190. doi: 10.1136/bmj.2.5090.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DICK G. W., DANE D. S. Vaccination against poliomyelitis with live virus vaccines. 4. A review of the present position. Br Med J. 1958 Nov 15;2(5106):1184–1186. doi: 10.1136/bmj.2.5106.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GELFAND H. M., POTASH L., LEBLANC D. R., FOX J. P. Intrafamilial and interfamilial spread of living vaccine strains of polioviruses. J Am Med Assoc. 1959 Aug 22;170(17):2039–2048. doi: 10.1001/jama.1959.03010170001001. [DOI] [PubMed] [Google Scholar]
  4. HORSTMANN D. M., NIEDERMAN J. C., MELNICK J. L., PAUL J. R. Poliomyelitis: comparison of responses of vaccinated and naturally immune humans to ingestion of attenuated poliovirus. Trans Assoc Am Physicians. 1957;70:91–101. [PubMed] [Google Scholar]
  5. HORSTMANN D. M., NIEDERMAN J. C., PAUL J. R. Attenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population. J Am Med Assoc. 1959 May 2;170(1):1–8. doi: 10.1001/jama.1959.03010010003001. [DOI] [PubMed] [Google Scholar]
  6. HORSTMANN D. M., NIEDERMAN J. C., RIORDAN J. T., PAUL J. R. The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina. Am J Hyg. 1959 Sep;70:169–184. doi: 10.1093/oxfordjournals.aje.a120068. [DOI] [PubMed] [Google Scholar]
  7. KOPROWSKI H., JERVIS G. A., NORTON T. W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952 Jan;55(1):108–124. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
  8. PAUL J. R. Properties of an ideal poliomyelitis vaccine. Bull N Y Acad Med. 1956 Oct;32(10):747–752. [PMC free article] [PubMed] [Google Scholar]
  9. PLOTKIN S. A., KOPROWSKI H., STOKES J., Jr Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics. 1959 Jun;23(6):1041–1062. [PubMed] [Google Scholar]
  10. SABIN A. B. Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci. 1955 Sep 27;61(4):924-38; discussion, 938-9. doi: 10.1111/j.1749-6632.1955.tb42551.x. [DOI] [PubMed] [Google Scholar]
  11. SALK J. E. Vaccination against poliomyelitis: an ounce of prevention. R Soc Health J. 1959 Jul-Aug;79:310–322. doi: 10.1177/146642405907900405. [DOI] [PubMed] [Google Scholar]
  12. VERLINDE J. D., WILTERDINK J. B., KRET A. Active immunization against poliomyelitis with live attenuated viruses. Arch Gesamte Virusforsch. 1959;8(5):549–564. doi: 10.1007/BF01242240. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES